<unk>  is indicated for the treatment of moderate-to-severe atopic dermatitis in adults who are candidates for systemic therapy.
Abrocitinib
Baricitinib
Gilteritinib
Erdafitinib
Upadacitinib
Tucatinib
Delgocitinib
Oclacitinib